Evaluation of the Feasibility of Endothelial Colony-Forming Cells to Develop Tissue-Engineered Vascular Grafts Based on the Gene Expression Profile Analysis
- PMID: 37064809
- PMCID: PMC10090920
- DOI: 10.17691/stm2022.14.3.02
Evaluation of the Feasibility of Endothelial Colony-Forming Cells to Develop Tissue-Engineered Vascular Grafts Based on the Gene Expression Profile Analysis
Abstract
The aim of the study was to assess the suitability of endothelial colony-forming cells in the development of tissue engineering constructs based on the study of the gene expression profile compared to mature endothelial cells.
Materials and methods: In the experiment, we used the endothelial colony-forming cells (ECFC) obtained from the peripheral blood of patients who underwent percutaneous coronary intervention. The cells were isolated on a Histopaque 1077 density gradient (Sigma-Aldrich, USA), and then cultured in EGM-2MV culture medium (Lonza, Switzerland). A commercial culture of primary human coronary artery endothelial cells (HCAEC) was used as a control. The cells were unfrozen and cultured according to the manufacturer's recommendations in MesoEndo Cell Growth Medium (Cell Applications, USA).The experiment was carried out in specialized μ-Luer plates in the perfusion system (IBIDI, Germany), which provided a continuous unidirectional flow of the culture medium with a shear stress of 5 dyn/cm2. Control plates were cultured under standard conditions for a similar period of time. Total RNA was isolated from cell samples. The expression of the genes NOTCH4, NRP2, PLAT, PLAU, NOTCH1, FLT1, COL4A2, CD34, SERPINE1, HEY2, MKI67, KLF4, LYVE1, FLT4 was assessed using a quantitative real-time polymerase chain reaction. The expression of the genes was calculated by the ΔCt method and expressed on a logarithmic (log10) scale as a fold change relating to the control samples.
Results: In mature endothelial cells HCAEC when exposed to a laminar flow, only the transcription factor KLF4 and venous differentiation NRP2 marker values increased significantly. ECFC showed statistically significant growth in KLF4, NRP2, CD34, and LYVE1, as well as PLAU expression decrease. In addition, we observed the overexpression of FLT4, LYVE1, NOTCH4, and NRP2 in ECFC in relation to HCAEC and HEY2 hypoexpression. CD34 overexpression characteristic of progenitor cells was also found. An increase in COL4A2 expression associated with type IV collagen synthesis was a characteristic feature of ECFC.
Conclusion: The gene expression profile of endothelial colony-forming cells is quite close to that of primary endothelial cells of the human coronary artery, and thus, the cells obtained from patients' peripheral blood can be used to develop personalized tissue-engineered constructs.
Keywords: coronary artery endothelial cells; endothelial colony-forming cells; gene expression; mononuclear fraction of peripheral blood; tissue engineering.
Conflict of interest statement
Conflicts of interest. The authors declare no conflicts of interest related to the present study.
Figures
Similar articles
-
Human Peripheral Blood-Derived Endothelial Colony-Forming Cells Are Highly Similar to Mature Vascular Endothelial Cells yet Demonstrate a Transitional Transcriptomic Signature.Cells. 2020 Apr 3;9(4):876. doi: 10.3390/cells9040876. Cells. 2020. PMID: 32260159 Free PMC article.
-
Peripheral blood derived endothelial colony forming cells as suitable cell source for pre-endothelialization of arterial vascular grafts under dynamic flow conditions.Microvasc Res. 2022 Sep;143:104402. doi: 10.1016/j.mvr.2022.104402. Epub 2022 Jun 24. Microvasc Res. 2022. PMID: 35753506
-
Purification and Functional Characterization of CD34-Expressing Cell Subsets Following Ex Vivo Expansion of Umbilical Cord Blood-Derived Endothelial Colony-Forming Cells.Stem Cells Dev. 2020 Jul;29(14):895-910. doi: 10.1089/scd.2020.0008. Epub 2020 Jun 11. Stem Cells Dev. 2020. PMID: 32336222
-
CD34 expression modulates tube-forming capacity and barrier properties of peripheral blood-derived endothelial colony-forming cells (ECFCs).Angiogenesis. 2016 Jul;19(3):325-38. doi: 10.1007/s10456-016-9506-9. Epub 2016 Apr 4. Angiogenesis. 2016. PMID: 27043316 Free PMC article.
-
Recent Advances in Endothelial Colony Forming Cells Toward Their Use in Clinical Translation.Front Med (Lausanne). 2018 Oct 23;5:295. doi: 10.3389/fmed.2018.00295. eCollection 2018. Front Med (Lausanne). 2018. PMID: 30406106 Free PMC article. Review.
Cited by
-
Multi-Omics Profiling of Human Endothelial Cells from the Coronary Artery and Internal Thoracic Artery Reveals Molecular but Not Functional Heterogeneity.Int J Mol Sci. 2023 Oct 9;24(19):15032. doi: 10.3390/ijms241915032. Int J Mol Sci. 2023. PMID: 37834480 Free PMC article.
-
Exploring vasculogenesis in the normal human kidney and clear cell renal cell carcinoma: insights from development to tumor progression and biomarkers for therapy response.Front Oncol. 2024 Apr 30;14:1375190. doi: 10.3389/fonc.2024.1375190. eCollection 2024. Front Oncol. 2024. PMID: 38746686 Free PMC article. Review.
References
-
- Prasain N., Lee M.R., Vemula S., Meador J.L., Yoshimoto M., Ferkowicz M.J., Fett A., Gupta M., Rapp B.M., Saadatzadeh M.R., Ginsberg M., Elemento O., Lee Y., Voytik-Harbin S.L., Chung H.M., Hong K.S., Reid E., O’Neill C.L., Medina R.J., Stitt A.W., Murphy M.P., Rafii S., Broxmeyer H.E., Yoder M.C. Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cells. Nat Biotechnol. 2014;32(11):1151–1157. doi: 10.1038/nbt.3048. - DOI - PMC - PubMed
-
- Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., Krasich R., Temm C.J., Prchal J.T., Ingram D.A. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007;109(5):1801–1809. doi: 10.1182/blood-2006-08-043471. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous